The consumer M&A
window just
reopened.

The consumer brand M&A market reopened in spring 2026, and the signal is in the spread, not any single deal. Danone paid roughly $1.2 billion for Huel. Church & Dwight paid $325 million for Miss Mouth's. Unilever absorbed Grüns for an undisclosed number. All three happened inside one quarter. The window is open, but what buyers are willing to pay, and for what, looks nothing like the last cycle. Founders building toward an exit and corporate teams sourcing their next acquisition both need to read the gap between those deal prices more carefully than the headline numbers.

In the space of about ten weeks this spring, three of the largest consumer companies on earth each wrote a check for a brand that did not exist a decade ago. Danone bought Huel. Unilever bought Grüns. Church & Dwight bought Miss Mouth's Messy Eater. L Catterton put Thorne on the block at a number that would have sounded delusional two years ago. After a long stretch where strategics sat on their hands and founders quietly wondered whether the exit market had closed for good, the buyers are back at the table.

I read these deals differently than most people who write about them, because I have sat on both sides. At WIN Brands Group I built and operated the kind of challenger brands that end up on an enterprise acquisition list. Then I crossed over and sourced and closed a several-hundred-million dollar DTC acquisition for an S&P 500 buyer, as the advisor on the corporate side of the table. So when a quarter like this one lands, I am not reading it for the headline. I am reading it for what the spread of outcomes tells the next founder and the next strategy team.

And the spread is the story. One of these deals cleared a billion dollars. Another cleared $325 million. The gap between them is where almost every real brand will actually exit, and it is the part the press releases bury. If you want to understand what makes an acquisition fail before close, or how strategics think about the buy/build/partner tradeoff, the pattern in this quarter tells you more than any M&A advisory deck. This page tracks every named consumer-brand acquisition of 2026, updated as new deals close, so the full run sits here, not just the headline set.

The 2026 consumer
acquisition wave,
on one page.

Here is the run of deals that reopened the conversation. Two of them closed, one is undisclosed on price, and one is an exploration rather than a signed deal. Together they map the range a buyer will actually pay in this market.

That is the headline set. Below is the full run: every named consumer-brand acquisition of 2026 so far, updated as new deals close.

For context on how fast the mood shifted: the two reference points everyone still quotes are from 2025, when PepsiCo paid $1.95 billion for Poppi and Church & Dwight paid up to $880 million for Touchland ($700M plus a sales-based earnout). Those were the deals that convinced founders a billion-dollar outcome was the target. They are also the deals quietly distorting everyone's expectations.

The framework matters because the same brand gets valued very differently depending on which bucket of buyer is sitting across the table. Miss Mouth's at 11.6 times EBITDA to Church & Dwight is a good disciplined price. The same brand pitched to a CPG major without a clear portfolio fit might struggle to find a strategic rationale. And pitched to a post-Thrasio aggregator, it would have sold at a lower multiple two years ago when the aggregator model was still being funded. Knowing which buyer type your brand is most legible to is half the work of structuring the acquisition process.

Two deals, two completely
different valuation
frameworks.

Look at the two closed deals side by side and you can see the buyers using different lenses, on purpose. Danone paid roughly 22 times EBITDA for Huel, a premium multiple that only makes sense if you believe complete nutrition is a durable, expanding category and Huel is the brand that owns it globally. That is a strategic-conviction price, not a financial-discipline price.

Church & Dwight paid about 4.1 times sales and 11.6 times EBITDA for Miss Mouth's. On their own last four acquisitions, that is the cheapest they have been on an EBITDA basis. They bought a brand doing roughly $80 million in net sales at a 35 percent EBITDA margin, the number one stain treatment on Amazon with ninety thousand reviews, and they bought it on math a CFO can defend in a board meeting without flinching.

There is one more wrinkle worth naming. Miss Mouth's came out of the Thrasio estate, and Thrasio is bankrupt. So part of that 11.6 times was not pure strategic logic, it was a good asset at a motivated price. That matters, because it means the cleanest comp in the quarter carries an asterisk: the buyer got a deal partly because the seller had to move. Do not build your own valuation model on someone else's distress.

The practical implication for a founder: the multiple a strategic pays is a function of three variables. How much competition they face for the asset. How cleanly the brand's revenue survives without the founder and without heavy paid-media support. And how much of a strategic premium they are willing to assign to the category position versus what the financial model alone would justify, which is why category sets the range before the brand ever does: beauty brand acquisition multiples in 2026 sit in a very different band than supplements or food. The contribution margin teardown is often where the difference shows up first in diligence. Brands with high gross margins but thin contribution margins after shipping, returns, and media costs get revalued fast once a corporate finance team looks at the actuals.

On the Grüns deal, the undisclosed price is actually informative in its own way. A brand that raised at roughly a $500 million Series B valuation in 2025 selling to Unilever shortly after, with no disclosed price, often signals one of two things: the founder took a deal that was below the last valuation and did not want to advertise it, or the sale price was compelling enough that both sides preferred confidentiality. For a three-year-old brand, either reading tells you something about how quickly Unilever was willing to act on a category bet. That speed is the part worth studying.

The billion-dollar deals
are the exception.
The $325M deal is the rule.

This is the part I want every founder to sit with. The Poppi, Huel, and Grüns headlines set an anchor in people's heads that a great consumer brand exits for a billion dollars or more. For all but a tiny handful of brands, that number is fantasy. A $1B-plus outcome requires category-defining scale, a genuine bidding dynamic, and usually a few years of luck on top of execution. It is not a plan. It is a lottery ticket that occasionally pays.

A $300 to $500 million outcome, on the other hand, is a generational result that is actually within reach for a well-run brand. Miss Mouth's is the relatable case: a focused product, a dominant listing, real profitability, and a clean strategic fit. That is a path a disciplined operator can reverse-engineer. The billion-dollar path mostly cannot be reverse-engineered, which is exactly why chasing it leads founders to over-raise, over-spend, and price themselves out of the only buyers who were ever realistically going to call.

In 2026, strategics are
buying proven demand.
Not potential.

The through-line across all four of these targets is that none of them are bets on a story. Huel has scaled revenue and a real subscription engine. Miss Mouth's is the top listing in its Amazon category with ninety thousand reviews and a 35 percent margin. Grüns built one of the largest brands in its supplement niche in under three years. Thorne more than doubled revenue from roughly $229 million to over $500 million under L Catterton, compounding north of 30 percent a year. These are not pre-product-market-fit acquisitions. They are buyers paying to own demand that has already been proven in the market.

That is a meaningful shift from the 2021 era, when strategics and growth funds would pay up for narrative and a steep top-line curve. The capital cost more now, boards are less forgiving, and every buyer in this list underwrote against profitability or durable category leadership, not just growth. If you want to be acquired in this market, the asset you are building is not a pitch deck. It is a profit-and-loss statement and a defensible position in a category a strategic wants to own.

First-party data is also now a real line item in the acquisition thesis, and it was not always. A brand with a strong owned email list, a genuine subscription cohort, and customer data that the strategic can use to target adjacent buyers in their existing portfolio is worth more than the same brand with equivalent revenue but 100% retail dependency. The challenger brand threat model is exactly what enterprise strategy teams are using to screen inbound: they want to know whether they are buying a community, a channel position, or a product, because the integration risk and the premium they will pay are different for each.

Thorne is the most interesting case in the quarter precisely because it has not yet sold. L Catterton took Thorne private at roughly $680 million enterprise value in 2023, compounded revenue significantly over the hold period, and is now testing whether a strategic will pay up to four times that. That gap, from $680 million acquisition to up to $4 billion exploration, is a direct bet that the VMS and longevity supplement category has become strategically important enough that a major CPG or healthcare company will pay a conviction price. Whether that bet lands will tell everyone a lot about where the ceiling is in the current market.

If you're the strategic,
the window rewards
discipline and speed.

For the enterprise buyer, this quarter is a reminder that the best deals are available right now, and that the math still has to work. Church & Dwight did not stretch for Miss Mouth's. They found a profitable leader, paid the cheapest EBITDA multiple of their recent run, and moved while a distressed seller created the opening. That is the model: know your categories cold, have a target list ready, and be the buyer who can close fast when the window opens, rather than the one who spends nine months in committee while a competitor signs the deal.

The flip side is the one I watch enterprises get wrong constantly. They wait too long, let a challenger compound for two or three extra years, and then overpay defensively for a brand that has gotten more expensive and a founder relationship that has gotten more strained. The whole argument for that is laid out in the DTC acquisition playbook, and the part that decides the outcome is not the purchase price at all, it is the first ninety days after close. Buy a community-driven brand and run it through corporate marketing review and you will destroy the thing you paid for inside eighteen months.

The enterprise teams that move well in this market share a few common habits. They maintain a live target list of brands in their priority categories, updated quarterly, so that when a sell-side signal appears they already know the company and have a relationship with the founder. They have done their financial pre-read before the first meeting, not during exclusivity. And they have a committed integration lead and a stated integration philosophy before the deal is signed, not improvised after close. The holding company acquisition mistakes post covers the operational version of this in detail, but for a corporate buyer the same logic applies at a larger scale.

There is also a category intelligence piece that matters more in this cycle than in 2021. In 2021, a strategic could afford to learn about a challenger brand during the acquisition process because valuations were so high that moving fast and overpaying felt like the cost of admission. Now that buyers are paying disciplined multiples, the diligence process has to be faster and the category conviction has to be formed before the process starts. Enterprises that are losing to DTC challengers consistently have the same root problem: they do not track the challenger landscape closely enough to act before the brand has already grown too expensive.

If you're building to sell,
build the brand a buyer
can underwrite.

The clearest lesson in this whole wave is that the brands getting bought look like profitable, focused category leaders, not like growth-at-all-costs machines hoping a strategic shows up before the cash runs out. If your exit thesis depends on a billion-dollar bid, you are building for the wrong buyer. If it depends on being the most profitable, most defensible leader in a category a strategic wants to own, you are building for the buyer who is actually writing checks in 2026.

Concretely, that means margin is a feature, not an afterthought. It means owning a category position you can describe in one sentence. It means first-party data and a customer relationship that survives a change of ownership. And it means resisting the raise that only makes sense at a fantasy valuation. I go deeper on exactly which numbers a strategic underwrites in the companion piece on the $325 million exit that should reset your expectations.

The timing question is also real and often handled poorly. Most founders either think too early about selling, when the brand is not yet differentiated enough to command a real premium, or wait too long, after raising at a valuation that prices out the realistic buyer pool. The sweet spot tends to be when you have a clear category position, 18-24 months of profitability at a defensible margin, and at least two credible strategic buyers who would be hurt by a competitor owning the asset. That last part is more important than most founders realize. A deal only gets competitive when both sides of a potential strategic conflict want the brand. One motivated buyer is a negotiation. Two competing buyers with strategic stakes in the outcome is an auction.

The other thing the 2026 wave confirms is that the founding story still matters to the integration, even if it does not drive the purchase price. Buyers are paying for customer trust and community authenticity. Those things are tied to the founder more than most corporate buyers admit during the process, and the first 48 hours after acquiring an ecommerce brand is often when that becomes obvious. A clean transition plan, with the founder staying on long enough for the community to absorb the change, is worth more than most of the deal structure debates that consume the late stages of a process.

I have broken several of these deals down on their own, because the pattern repeats with local color. Prestige paying just over a billion for Breathe Right, which I unpack in the Breathe Right and Prestige deal breakdown, is a strategic buying a durable OTC franchise, while Advent's bet on Salt & Stone is private equity underwriting a premium body-care brand. The roll-up machinery is getting more organized too. Celebrity DTC brands now exit into PE roll-ups, home is shaping up as the 2026 consolidation target, and the quiet mechanic behind a lot of it is the operate-versus-license split that decides which parts of a brand a buyer actually keeps. For the other half of the money flow, the capital going into these brands rather than the checks buying them out, see the companion 2026 consumer funding-rounds tracker.

The window is open. Strategics are paying premiums for category leaders and disciplined prices for profitable ones, and they are doing both in the same quarter. The founders who do well in this market will be the ones who built for the realistic exit instead of the lottery ticket, and the enterprises who do well will be the ones who moved early and integrated like they understood what they bought.

If you are building toward an exit, or evaluating a brand to acquire, the work page has the relevant case studies and the inquiry form is the fastest way to a conversation. I have been on both sides of this table, and that is the entire point of the conversation.

Questions founders and
buyers ask me most
about the 2026 market.

A note on sources: the consolidated read on this quarter was prompted by the consumer M&A tracking that Drew Fallon publishes in his Making Cents newsletter (he's also worth a follow on X). The deal figures here are drawn from public filings and reporting: Danone's acquisition of Huel, Unilever's acquisition of Grüns, Church & Dwight's Miss Mouth's and Touchland announcements, PepsiCo's Poppi close, and Axios reporting on L Catterton's Thorne process. The interpretation, and any errors in it, are mine.

Questions I keep
getting asked.